ADVERSE DRUG REACTIONS OF HAART THERAPY AMONG HIV/AIDS PATIENTS TREATED AT INFECTIOUS DISEASE CLINIC

Author(s)

Khan AH1, Syed Sulaiman SA1, Khan K1, Aftab RA1, Soo CT2
1Universiti Sains Malaysia, Minden, Malaysia, 2Medical Department Penang Hospital, Penang, Minden, Malaysia

OBJECTIVES: Current study is aimed to explore and to observe adverse drug reactions occurrence of antiretroviral drugs among HIV/AIDS patients METHODS: An observational retrospective study of all patients diagnosed of HIV infection and on HAART therapy from Jan 2007 to Dec 2012 was conducted at infectious disease department of Hospital Pulau Pinang, Malaysia. Patient socio-demographic details along with clinical features were recorded. The reported ADRs were assessed for causality by using Noranjo’s algorithm scale. Data was descriptively analyzed by using statistical package for social sciences (SPSS 20).  RESULTS: Out of 743 patients that underwent HAART therapy, 571 (76.8%) were male and 172 (23.1%) were female patients. Overall 314 (42.2%) patients had experienced adverse drug reactions. A total number of 425 (57.2%) adverse drug reactions were reported among which 311 (73.1%) occurred in males and 114 (26.8%) in female patients. Lipodystrophy 151 (35.5%) was the most common ADR reported; in male 126 (29.6%) and 25 (5.8%) female patients were recorded. Lipodystrophy was followed by skin rashes 80 (18.8%) that included 56 (13.1%) male and 24 (5.7%) female patients. Anaemia was reported 74 (17.4%), of which 49 (11.5%) observed in male and 25 (5.8%) female patients. A statistical significant relationship on Chi-square test was observed between the gender and the occurrence of adverse drug reactions (p-value =0.002). However on univariate analysis the relationship between ADRs with gender resulted in insignificant value (p-value=0.267, 95% CI= 0.862 – 1.712, Odd ratio= 1.215) CONCLUSIONS: The study indicates the incidence of adverse drug reactions is higher in male than in female patients. However, a multicenter study with a large sample size may provide us with better understanding of this relationship

Conference/Value in Health Info

2014-09, ISPOR Asia Pacific 2014, Beijing, China

Value in Health, Vol. 17, No. 7 (November 2014)

Code

PIN2

Topic

Epidemiology & Public Health

Topic Subcategory

Safety & Pharmacoepidemiology

Disease

Infectious Disease (non-vaccine)

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×